PROJECT MANAGEMENT IN BIO-PHARMACEUTICAL R&D: A REVIEW OF TRADITIONAL AND AGILE METHODOLOGIES

Abstract

In the biopharmaceutical R&D domain, a lack of mastery of the right approach to project management could mean the difference between breakthrough innovation and costly delays. In an attempt to probe these contrasting worlds, this review goes deep into the essence of predictive (Waterfall, Stage-Gate) versus adaptive (AI, Agile, Scrum) methodologies and their respective impacts on strategic decision making, risk management, and pharma research innovation potential. However, the regulatory complexities and documentation burdens do not ease out according to the Agile methodologies that fuel rapid iteration in evolving teams and accelerate the speed of development cycles. Using performance metrics, organizational models, and transformative case studies, this review demonstrates how one model outperforms the other, what is lacking in a certain method, and how hybrid frameworks redefine best practices. This review benefits researchers, project managers, and strategists by clarifying how evolving methodologies can drive the next wave of innovation in the field.